News

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...
Illumina's recently released Q1 FY 2021 earnings has seemingly put to rest the fears of slowing growth in the core business.
A top Illumina executive explains what the biggest misconception about the company is -- and what's most important over the long run.
Bengaluru-based MedGenome, a company into genomics research and diagnostics has bought the Illumina Hiseq X Ten machine, which is used for genome sequencing. In a statement, MedGenome said that it ...
With the addition of these new NovaSeq sequencers to its existing array of 30 Illumina HiSeq X and 10 PacBio Sequel systems, Novogene now offers the largest and most advanced sequencing capacity ...
The lowest price for HiSeq — Illumina’s former top-end system — is a base $6 million for a set of five machines. Originally, the system sold in sets of 10 for $10 million a system.
California / Bangalore, India 1st October, 2016: MedGenome today announced that it has purchased the Illumina Hiseq X Ten platform to fuel its genomic research services capability and capacity ...
With spin-off investments Grail and Helix, and a new software-savvy CEO, Illumina is poised to make DNA an even bigger part of your life.
San Diego-based Illumina said Tuesday its HiSeq X system can now be used to perform whole-genome sequencing of plants, livestock and other non-human species.
Illumina is riding high off its HiSeq X sequencing systems, meeting increased demand with expanded facilities and ambitious plans for growth. Now, the company is rolling out a service to help labs ...